449 related articles for article (PubMed ID: 15106259)
1. Velnacrine for Alzheimer's disease.
Birks J; Wilcock GG
Cochrane Database Syst Rev; 2004; (2):CD004748. PubMed ID: 15106259
[TBL] [Abstract][Full Text] [Related]
2. Rivastigmine for Alzheimer's disease.
Birks J; Grimley Evans J; Iakovidou V; Tsolaki M; Holt FE
Cochrane Database Syst Rev; 2009 Apr; (2):CD001191. PubMed ID: 19370562
[TBL] [Abstract][Full Text] [Related]
3. Rivastigmine for Alzheimer's disease.
Birks JS; Grimley Evans J
Cochrane Database Syst Rev; 2015 Apr; (4):CD001191. PubMed ID: 25858345
[TBL] [Abstract][Full Text] [Related]
4. Rivastigmine for Alzheimer's disease.
Birks J; Grimley Evans J ; Iakovidou V; Tsolaki M
Cochrane Database Syst Rev; 2000; (4):CD001191. PubMed ID: 11034705
[TBL] [Abstract][Full Text] [Related]
5. Galantamine for Alzheimer's disease.
Olin J; Schneider L
Cochrane Database Syst Rev; 2002; (3):CD001747. PubMed ID: 12137632
[TBL] [Abstract][Full Text] [Related]
6. Donepezil for dementia due to Alzheimer's disease.
Birks JS; Harvey RJ
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001190. PubMed ID: 29923184
[TBL] [Abstract][Full Text] [Related]
7. Galantamine for Alzheimer's disease.
Olin J; Schneider L
Cochrane Database Syst Rev; 2001; (4):CD001747. PubMed ID: 11687119
[TBL] [Abstract][Full Text] [Related]
8. Rivastigmine for Alzheimer's disease.
Birks J; Iakovidou V; Tsolaki M
Cochrane Database Syst Rev; 2000; (2):CD001191. PubMed ID: 10796621
[TBL] [Abstract][Full Text] [Related]
9. Donepezil for dementia due to Alzheimer's disease.
Birks JS; Harvey R
Cochrane Database Syst Rev; 2003; (3):CD001190. PubMed ID: 12917900
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group.
Antuono PG
Arch Intern Med; 1995 Sep; 155(16):1766-72. PubMed ID: 7654110
[TBL] [Abstract][Full Text] [Related]
11. Rivastigmine for Alzheimer's disease.
Birks JS; Chong LY; Grimley Evans J
Cochrane Database Syst Rev; 2015 Sep; 9(9):CD001191. PubMed ID: 26393402
[TBL] [Abstract][Full Text] [Related]
12. WITHDRAWN: Tacrine for Alzheimer's disease.
Qizilbash N; Birks J; Lopez Arrieta J; Lewington S; Szeto S
Cochrane Database Syst Rev; 2007 Jul; (3):CD000202. PubMed ID: 17636619
[TBL] [Abstract][Full Text] [Related]
13. Velnacrine for the treatment of Alzheimer's disease: a double-blind, placebo-controlled trial. The Mentane Study Group.
Zemlan FP
J Neural Transm (Vienna); 1996; 103(8-9):1105-16. PubMed ID: 9013398
[TBL] [Abstract][Full Text] [Related]
14. Metrifonate for Alzheimer's disease.
López-Arrieta JM; Schneider L
Cochrane Database Syst Rev; 2006 Apr; (2):CD003155. PubMed ID: 16625573
[TBL] [Abstract][Full Text] [Related]
15. Donepezil for mild and moderate Alzheimer's disease.
Birks JS; Melzer D; Beppu H
Cochrane Database Syst Rev; 2000; (4):CD001190. PubMed ID: 11034704
[TBL] [Abstract][Full Text] [Related]
16. Donepezil for dementia due to Alzheimer's disease.
Birks J; Harvey RJ
Cochrane Database Syst Rev; 2006 Jan; (1):CD001190. PubMed ID: 16437430
[TBL] [Abstract][Full Text] [Related]
17. Galantamine for Alzheimer's disease.
Olin J; Schneider L
Cochrane Database Syst Rev; 2001; (1):CD001747. PubMed ID: 11279727
[TBL] [Abstract][Full Text] [Related]
18. Physostigmine for Alzheimer's disease.
Coelho F; Birks J
Cochrane Database Syst Rev; 2001; 2001(2):CD001499. PubMed ID: 11405996
[TBL] [Abstract][Full Text] [Related]
19. Donepezil for mild and moderate Alzheimer's disease.
Birks J S; Melzer D
Cochrane Database Syst Rev; 2000; (2):CD001190. PubMed ID: 10796620
[TBL] [Abstract][Full Text] [Related]
20. Tacrine for Alzheimer's disease.
Qizilbash N; Birks J; López-Arrieta J; Lewington S; Szeto S
Cochrane Database Syst Rev; 2000; 1999(2):CD000202. PubMed ID: 10796507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
